Mirae Asset Global Investments Co., Ltd. Collegium Pharmaceutical, Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,242 shares of COLL stock, worth $42,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,242

Previous 1,056 17.61%

Holding current value

$42,575

Previous $31,000 16.13%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$24.67 - $30.44 $4,588 - $5,661	186 Added 17.61%	1,242 $36,000
Q1 2025 Apr 24, 2025	SELL	$28.04 - $33.91 $532 - $644	-19 Reduced 1.77%	1,056 $31,000
Q4 2024 Jan 27, 2025	SELL	$28.61 - $41.86 $2,574 - $3,767	-90 Reduced 7.73%	1,075 $30,000
Q3 2024 Oct 23, 2024	BUY	$31.4 - $39.07 $5,903 - $7,345	188 Added 19.24%	1,165 $45,000
Q2 2024 Jul 30, 2024	SELL	$31.36 - $39.99 $470,431 - $599,889	-15,001 Reduced 93.89%	977 $31,000
Q1 2024 May 01, 2024	SELL	$31.23 - $40.91 $22,954 - $30,068	-735 Reduced 4.4%	15,978 $620,000
Q4 2023 Jan 24, 2024	BUY	$21.16 - $30.8 $18,366 - $26,734	868 Added 5.48%	16,713 $514,000
Q3 2023 Oct 26, 2023	BUY	$21.23 - $24.28 $721 - $825	34 Added 0.22%	15,845 $354,000
Q2 2023 Aug 10, 2023	SELL	$21.06 - $24.0 $1,221 - $1,392	-58 Reduced 0.37%	15,811 $339,000
Q1 2023 May 04, 2023	SELL	$23.0 - $29.88 $230 - $298	-10 Reduced 0.06%	15,869 $380,000
Q4 2022 Feb 09, 2023	SELL	$16.14 - $23.55 $32 - $47	-2 Reduced 0.01%	15,879 $368,000
Q3 2022 Nov 10, 2022	BUY	$15.46 - $20.1 $68,101 - $88,540	4,405 Added 38.38%	15,881 $255,000
Q2 2022 Jul 26, 2022	BUY	$14.22 - $20.88 $163,188 - $239,618	11,476 New	11,476 $203,000

Others Institutions Holding COLL

# of Institutions

241

Shares Held

36.4M

Call Options Held

52.5K

Put Options Held

200

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.17B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Collegium Pharmaceutical, Inc Transaction History